FindTrial
Sign In

The clinical effect of esketamine combined with propofol for conscious sedation and propofol for deep sedation during colonoscopy

The clinical effect of esketamine combined with propofol for conscious sedation and propofol for deep sedation during colonoscopy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200064552
Enrollment
Unknown
Registered
2022-10-11
Start date
2022-10-08
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Painless colonoscopy anesthesia sedation

Interventions

Group 1 :Conscious sedation with esketamine combined with propofol
Group 2:Deep sedation with propofol

Sponsors

The First Affiliated Hospital of Hunan Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients planning to undergo colonoscopy, aged 18-60 years, ASA grade 1/2, BMI: 18-25 kg/m2, without contraindications for colonoscopy, voluntarily participated in this study and signed the informed consent.

Exclusion criteria

Exclusion criteria: Hepatic and renal insufficiency, acute airway inflammation in the past 2 weeks, severe asthma, possible or proven difficult airway, history of narcotic drug abuse, history of allergy to analgesics or sedatives, mental disorders, pregnant and lactating women

Design outcomes

Primary

MeasureTime frame
Safety measures;Effectiveness index;—

Secondary

MeasureTime frame
Recovery time and incidence of adverse reactions;patient satisfaction;—

Countries

China

Contacts

Public ContactLizhu Xiao

The First Affiliated Hospital of Hunan Medical College

1521611240@qq.com+86 15974038469

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026